Hamilton Thorne Ltd. (HTL) is a public company traded on the Toronto Venture Exchange.
HTL is a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets.
The group began accelerating its growth by completing the acquisition of the Gynemed & Co GmbH (2017), Planer Ltd. (2019), Tek-Event (2021), IVFTech ApS (2021) and Microptic S.L. (2022).
Today, while its primary focus is serving laboratories in the ART field, the products and services are provided to a diverse customer base, from in vitro fertilization (IVF) clinics and pharmaceutical companies to animal research facilities and academic establishments worldwide.